Financial Impact of Hidradenitis Suppurativa in Spain - Summary - MDSpire

Financial Impact of Hidradenitis Suppurativa in Spain

  • By

  • Eva Vilarrasa

  • Joaquín Borrás-Blasco

  • Silvia Lobo-Benito

  • Marta Loro-Pérez

  • Marta Garcia Núñez-García

  • Juan Oliva-Moreno

  • David Palacios-Martínez

  • Félix Rubial-Bernárdez

  • Yoana Ivanova-Markova

  • Mathilde Daheron

  • Javier Bellas

  • Antonio Martorell

  • February 22, 2026

  • 0 min

Share

Objective:

To estimate the economic burden of Hidradenitis Suppurativa (HS) in Spain for individual patients and the overall diagnosed population, particularly emphasizing the role of disease severity in this estimation.

Key Findings:
  • The average annual cost per patient with HS is €39,535.10, with informal caregiving expenses quantified through patient surveys and expert consensus.
  • Informal caregiving expenses significantly contribute to the overall economic burden.
  • HS leads to lower employment rates and reduced work productivity.
Interpretation:

The findings highlight the substantial economic impact of HS on patients and society, underscoring the critical need for early diagnosis and effective treatment to alleviate this burden and improve healthcare policy.

Limitations:
  • The study relies on estimates and assumptions regarding prevalence and costs.
  • Potential underreporting of costs associated with informal caregiving.
  • Survey responses may be biased due to the involvement of the patient association.
Conclusion:

Addressing the economic burden of HS is crucial for healthcare decision-makers to prioritize health policies and allocate resources effectively.

Original Source(s)

Financial Impact of Hidradenitis Suppurativa in Spain

  • by Eva Vilarrasa, Joaquín Borrás-Blasco, Silvia Lobo-Benito, Marta Loro-Pérez, Marta Garcia Núñez-García, Juan Oliva-Moreno, David Palacios-Martínez, Félix Rubial-Bernárdez, Yoana Ivanova-Markova, Mathilde Daheron, Javier Bellas, Antonio Martorell

  • February 22, 2026

Related Content

HS Linked to Higher Self-Harm, Suicide Risk

Prior self-harm episodes and nonviolent methods are more common among HS patients who die by suicide, new research finds.

Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches

Exploring Addictive Behaviors in Patients with Hidradenitis Suppurativa: Findings from a Cross-Sectional Pilot Study